Sign In
Buy CBIO
$17.98
+0.98 (+5.73%)
At Close: Jun 03, 2026
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
09:15pm, Wednesday, 12'th Feb 2020
Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company developing novel treatments for hemophilia and other rare bleeding disorders (the Company), today announced that it is off
16 Healthcare Stocks Moving In Friday's Pre-Market Session
12:39pm, Friday, 07'th Feb 2020
Gainers
• Assertio Therapeutics, Inc. (NASDAQ:ASRT) stock increased by 57.7% to $1.64 during Friday's pre-market session.
• Seelos Therapeutics, Inc. (NASDAQ:SEEL)...
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
12:32pm, Friday, 07'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
Catalyst Biosciences, Inc. (CBIO), today announced positive efficacy and safety data from its Phase 2b trial of DalcA, a next-generation subcutaneously (SQ) administered Factor IX (FIX) therapy being
Edited Transcript of BDX earnings conference call or presentation 6-Feb-20 1:00pm GMT
02:58am, Friday, 07'th Feb 2020
Q1 2020 Becton Dickinson and Co Earnings Call
Becton, Dickinson (BDX) Q1 Earnings Beat, Revenues Rise Y/Y
02:24pm, Thursday, 06'th Feb 2020
Becton, Dickinson (BDX) sees softness in BD Medical unit, slashes FY20 view.
The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus
06:04pm, Sunday, 02'nd Feb 2020
Biotech stocks see-sawed through the week ended Jan. 31 and ended the month lower overall. Big pharma earnings of the week were mostly disappointing. Pfizer Inc. (NYSE: PFE ) reported disappointing fo
RegenXBio (RGNX) Receives a Rating Update from a Top Analyst
04:20pm, Wednesday, 29'th Jan 2020
In a report released today, Gbola Amusa from Chardan Capital reiterated a Buy rating on RegenXBio (RGNX), with a price target of $150.00. The company's
RegenXBio (RGNX) Receives a Rating Update from a Top Analyst
04:20pm, Wednesday, 29'th Jan 2020
In a report released today, Gbola Amusa from Chardan Capital reiterated a Buy rating on RegenXBio (RGNX – Research Report),
Chardan Capital Sticks to Their Buy Rating for uniQure (QURE)
06:50am, Wednesday, 29'th Jan 2020
Chardan Capital analyst Gbola Amusa reiterated a Buy rating on uniQure (QURE) today and set a price target of $125.00. The company's shares closed last
Chardan Capital Sticks to Their Buy Rating for uniQure (QURE)
06:50am, Wednesday, 29'th Jan 2020
Chardan Capital analyst Gbola Amusa reiterated a Buy rating on uniQure (QURE – Research Report) today and set a price
Catalyst Biosciences Announces Oral and Poster Presentations at the 13th Annual EAHAD Congress
01:00pm, Monday, 27'th Jan 2020
SOUTH SAN FRANCISCO, Calif., Jan. 27, 2020 -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced one oral and three poster presentations at the 13th Annual Congress of.
Audentes Therapeutics (BOLD) Gets a Hold Rating from Chardan Capital
12:13pm, Monday, 20'th Jan 2020
Chardan Capital analyst
Gbola Amusa
maintained a
Hold
rating on Audentes Therapeutics (
BOLD
–
Research Report
) on January 18. The company’s shares closed last Monday at $59.97, close to its 52-w
Catalyst Biosciences Announces Addition of Geoffrey Shiu Fei Ling, M.D. and Sharon Tetlow to Board of Directors
01:00pm, Friday, 17'th Jan 2020
Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company developing novel treatments for hemophilia and other rare bleeding disorders, today announced the appointment of Geoffrey
20 Biopharma Stocks for Huge Upside Potential in 2020
12:05pm, Saturday, 11'th Jan 2020
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
